Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abbott India is a leading pharmaceutical company in India and a subsidiary of the global healthcare giant Abbott Laboratories. The company specializes in the development and distribution of a wide range of pharmaceutical products across therapeutic areas such as women's health, gastroenterology, cardiology, and metabolic disorders. With a strong portfolio of trusted brands like Thyronorm, Duphaston, and Udiliv, Abbott India has established itself as a dominant player in the Indian domestic market. The company operates a state-of-the-art manufacturing facility in Goa and maintains an extensive distribution network reaching millions of patients. As a publicly traded entity on the Indian stock exchanges, it is recognized for its consistent growth and commitment to providing high-quality healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abbott India.